These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 36939254)

  • 41. Antibiotic use attenuates response to immune checkpoint blockade in urothelial carcinoma via inhibiting CD74-MIF/COPA: revealing cross-talk between anti-bacterial immunity and anti-tumor immunity through a tumor marker prognostic study.
    Song Y; Peng Y; Qin C; Jiang S; Lin J; Lai S; Wu J; Ding M; Du Y; Yu L; Xu T
    Int J Surg; 2024 Jul; ():. PubMed ID: 38995167
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Single-cell landscape reveals active cell subtypes and their interaction in the tumor microenvironment of gastric cancer.
    Li Y; Hu X; Lin R; Zhou G; Zhao L; Zhao D; Zhang Y; Li W; Zhang Y; Ma P; Ren H; Liao X; Niu P; Wang T; Zhang X; Wang W; Gao R; Li Q; Church G; He J; Chen Y
    Theranostics; 2022; 12(8):3818-3833. PubMed ID: 35664061
    [No Abstract]   [Full Text] [Related]  

  • 43. Clinicopathologic and Genomic Characterization of PD-L1 Positive Urothelial Carcinomas.
    Huang RSP; Haberberger J; Harries L; Severson E; Duncan DL; Ferguson NL; Hemmerich A; Edgerly C; Murugesan K; Xiao J; McEwan D; Holmes O; Hiemenz M; Venstrom J; Elvin JA; Creeden J; Lin DI; Ross JS; Ramkissoon SH
    Oncologist; 2021 May; 26(5):375-382. PubMed ID: 33687775
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Spatial relationships in the urothelial and head and neck tumor microenvironment predict response to combination immune checkpoint inhibitors.
    Gil-Jimenez A; van Dijk N; Vos JL; Lubeck Y; van Montfoort ML; Peters D; Hooijberg E; Broeks A; Zuur CL; van Rhijn BWG; Vis DJ; van der Heijden MS; Wessels LFA
    Nat Commun; 2024 Mar; 15(1):2538. PubMed ID: 38514623
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Integrated proteogenomic characterization of urothelial carcinoma of the bladder.
    Xu N; Yao Z; Shang G; Ye D; Wang H; Zhang H; Qu Y; Xu F; Wang Y; Qin Z; Zhu J; Zhang F; Feng J; Tian S; Liu Y; Zhao J; Hou J; Guo J; Hou Y; Ding C
    J Hematol Oncol; 2022 Jun; 15(1):76. PubMed ID: 35659036
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification and validation of a novel signature based on cell-cell communication in head and neck squamous cell carcinoma by integrated analysis of single-cell transcriptome and bulk RNA-sequencing.
    Wang J; Sun HC; Cao C; Hu JD; Qian J; Jiang T; Jiang WB; Zhou S; Qiu XW; Wang HL
    Front Oncol; 2023; 13():1136729. PubMed ID: 37213285
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of lymphocyte-specific programmed cell death protein 1 receptor expression and cytokines in blood and urine in canine urothelial carcinoma patients.
    Pinard CJ; Stegelmeier AA; Bridle BW; Mutsaers AJ; Wood RD; Wood GA; Woods JP; Hocker SE
    Vet Comp Oncol; 2022 Jun; 20(2):427-436. PubMed ID: 34797014
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabolic heterogeneity in clear cell renal cell carcinoma revealed by single-cell RNA sequencing and spatial transcriptomics.
    Yang G; Cheng J; Xu J; Shen C; Lu X; He C; Huang J; He M; Cheng J; Wang H
    J Transl Med; 2024 Feb; 22(1):210. PubMed ID: 38414015
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intercellular Molecular Crosstalk Networks within Invasive and Immunosuppressive Tumor Microenvironment Subtypes Associated with Clinical Outcomes in Four Cancer Types.
    Wei J; Yu W; Wu L; Chen Z; Huang G; Hu M; Du H
    Biomedicines; 2023 Nov; 11(11):. PubMed ID: 38002057
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Single-cell Transcriptomic Architecture Unraveling the Complexity of Tumor Heterogeneity in Distal Cholangiocarcinoma.
    Li H; Qu L; Yang Y; Zhang H; Li X; Zhang X
    Cell Mol Gastroenterol Hepatol; 2022; 13(5):1592-1609.e9. PubMed ID: 35219893
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing.
    Hao X; Zheng Z; Liu H; Zhang Y; Kang J; Kong X; Rong D; Sun G; Sun G; Liu L; Yu H; Tang W; Wang X
    Redox Biol; 2022 Oct; 56():102463. PubMed ID: 36108528
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of Genomic Characterization in Upper Tract Urothelial Carcinoma and Urothelial Carcinoma of the Bladder.
    Yang K; Yu W; Liu H; Ding F; Zhang Y; Zhang Y; Wang W; Lou F; Cao S; Wang H; He Z
    Oncologist; 2021 Aug; 26(8):e1395-e1405. PubMed ID: 34050578
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer.
    Heidegger I; Fotakis G; Offermann A; Goveia J; Daum S; Salcher S; Noureen A; Timmer-Bosscha H; Schäfer G; Walenkamp A; Perner S; Beatovic A; Moisse M; Plattner C; Krogsdam A; Haybaeck J; Sopper S; Thaler S; Keller MA; Klocker H; Trajanoski Z; Wolf D; Pircher A
    Mol Cancer; 2022 Jun; 21(1):132. PubMed ID: 35717322
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multiplex immunofluorescence and single-cell transcriptomic profiling reveal the spatial cell interaction networks in the non-small cell lung cancer microenvironment.
    Peng H; Wu X; Liu S; He M; Xie C; Zhong R; Liu J; Tang C; Li C; Xiong S; Zheng H; He J; Lu X; Liang W
    Clin Transl Med; 2023 Jan; 13(1):e1155. PubMed ID: 36588094
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Integrating single-cell and spatial analysis reveals MUC1-mediated cellular crosstalk in mucinous colorectal adenocarcinoma.
    Zhou H; Shen Y; Zheng G; Zhang B; Wang A; Zhang J; Hu H; Lin J; Liu S; Luan X; Zhang W
    Clin Transl Med; 2024 May; 14(5):e1701. PubMed ID: 38778448
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Spatial heterogeneity of tumor microenvironment influences the prognosis of clear cell renal cell carcinoma.
    Zhang D; Ni Y; Wang Y; Feng J; Zhuang N; Li J; Liu L; Shen W; Zheng J; Zheng W; Qian C; Shan J; Zhou Z
    J Transl Med; 2023 Jul; 21(1):489. PubMed ID: 37474942
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Single-cell transcriptome analysis of tumor immune microenvironment characteristics in colorectal cancer liver metastasis.
    Geng Y; Feng J; Huang H; Wang Y; Yi X; Wei S; Zhang M; Li Z; Wang W; Hu W
    Ann Transl Med; 2022 Nov; 10(21):1170. PubMed ID: 36467341
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CD38 marks the exhausted CD8
    Reolo MJY; Otsuka M; Seow JJW; Lee J; Lee YH; Nguyen PHD; Lim CJ; Wasser M; Chua C; Lim TKH; Leow WQ; Chung A; Goh BKP; Chow PKH; DasGupta R; Yeong JPS; Chew V
    Front Immunol; 2023; 14():1182016. PubMed ID: 37377962
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor in urothelial carcinoma.
    Zhong Q; Shou J; Ying J; Ling Y; Yu Y; Shen Z; Zhang Y; Li N; Shi Y; Zhou A
    Future Oncol; 2021 Aug; 17(22):2893-2905. PubMed ID: 34189951
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Spatially Distinct Reprogramming of the Tumor Microenvironment Based On Tumor Invasion in Diffuse-Type Gastric Cancers.
    Jeong HY; Ham IH; Lee SH; Ryu D; Son SY; Han SU; Kim TM; Hur H
    Clin Cancer Res; 2021 Dec; 27(23):6529-6542. PubMed ID: 34385296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.